Serum glutamic oxaloacetic transaminase (SGOT) =< 1.5 x ULN
Serum glutamic oxaloacetic transaminase (SGOT) =< 3 x normal
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 x ULN (CTCAE v 3.0 grade 0-1)
Serum glutamic-oxaloacetic transaminase (SGOT) =< 2.0 x upper limit of normal (ULN)
Alkaline phosphatase (hepatic) or serum glutamic-oxaloacetic transaminase (SGOT) > 3 times the upper normal limit
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.0 x upper normal limit (UNL)
Significant hepatic dysfunction (serum glutamic-oxaloacetic transaminase [SGOT] > 5x upper limit of normal; bilirubin > 3.0 mg/dL)
Serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase (SGPT) and alkaline phosphatase <3 times the ULN) unless due to organ involvement
Serum glutamic-oxaloacetic transaminase (SGOT) =< 1.5 times upper limit of normal (prior to biopsy)
Performed within 14 days (+ 3 working days) prior to registration: Serum glutamic-oxaloacetic transaminase (SGOT) and bilirubin < 2 times upper limit of normal (ULN).
Serum glutamic oxaloacetic transaminase (SGOT) > 5 x upper limit of normal
Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamic pyruvic transaminase (SGPT) less than or equal to 3 X the upper limit of normal (ULN) for the reference lab unless due to leukemia or congenital hemolytic disorder or bilirubin excretion disorder; patients with hepatic dysfunction (SGOT/SGPT up to less than or equal to 5 X ULN) due to organ infiltration by disease may be eligible after discussion with the principal investigator and appropriate dose adjustments will be considered
Serum glutamic oxaloacetic transaminase (SGOT) =< 3 x the upper limit of normal
Serum glutamic-oxaloacetic transaminase (SGOT) and alkaline phosphatase less than or equal to 2.5 x ULN (CTCAE v4 grade 1)
Serum glutamic oxaloacetic transaminase (SGPT) < 5 x upper limit of normal; some patients with minor deviations may be accepted on protocol after discussion with the PI
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 x ULN
Serum glutamic oxaloacetic transaminase (SGOT) > 5 x upper limit of normal
Alkaline phosphatase (hepatic) or serum glutamic oxaloacetic transaminase (SGOT) > 3 times the upper normal limit
Serum glutamic-oxaloacetic transaminase (SGOT) =< 2.5 × upper limit of normal of institution's normal range (ULN) (=< 5.0 × ULN with liver metastasis)
Serum glutamic oxaloacetic transaminase (SGOT) < 2 times upper limit of normal (ULN) (performed within 14 days prior to registration)
Severe hepatic disease (direct bilirubin > 3 mg/dl or serum glutamic oxaloacetic transaminase [SGOT] > 500)
Serum glutamic oxaloacetic transaminase (SGOT) < 5 x upper normal limits (UNL)
Serum glutamic-oxaloacetic transaminase (SGOT) < 2 x upper limit of normal (ULN) performed within 60 days of enrollment
Serum glutamic oxaloacetic transaminase (SGOT) < 108 u/L
Serum glutamic oxaloacetic transaminase (SGOT) =< 3 X laboratory normal
Serum glutamic oxaloacetic transaminase (SGOT) greater than 3.0 x ULN (CTCAE v4.0 grade 1) (if known hepatic metastases SGOT may be =< 5 x ULN)
Serum glutamic oxaloacetic transaminase (SGOT) =< 1.5 times upper limit of normal
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 times the upper limit of normal
Serum glutamic oxaloacetic transaminase (SGOT) < 2 x upper limit of normal (ULN) (or < 5 x ULN if liver is involved)
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 x ULN, CTCAE grade 1
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 x institutional upper limit normal
Serum glutamic oxaloacetic transaminase (SGOT) < 2 times upper limit of normal (ULN)
Serum glutamic oxaloacetic transaminase (SGOT) =< 1.5 x normal
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.0 times normal
Serum glutamic oxaloacetic transaminase (SGOT) less than or equal to 2.5 x ULN (CTCAE v4.0 grade 1)
Serum glutamic oxaloacetic transaminase (SGOT) > 3 times the upper limit of normal
Serum glutamic oxaloacetic transaminase (SGOT) =< 3 times normal
Serum glutamic oxaloacetic transaminase (SGOT) =< 3 x institutional upper limit of normal
Serum glutamic oxaloacetic transaminase (SGOT) < 1.5 times upper limit of normal
Serum glutamic oxaloacetic transaminase (SGOT) > 3 times the upper normal limit
Serum glutamic oxaloacetic transaminase (SGOT) > 150 IU or > 3 x upper limit of normal
Serum glutamic oxaloacetic transaminase (SGOT) or serum glutamic pyruvic transaminase (SGPT) < 3 times upper limits of normal =< 120 days prior to registration
Serum glutamic oxaloacetic transaminase (SGOT) < 1.5 times upper limit of normal
Serum glutamic-oxaloacetic transaminase (SGOT) =< 1.5 x upper limit of normal (ULN) obtained =< 180 days prior to registration
Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 x ULN
Serum glutamic oxaloacetic transaminase (SGOT) =< 1.5 x upper limit of normal (ULN)
Serum glutamic-oxaloacetic transaminase (SGOT) and alkaline phosphatase less than or equal to 2.5 x ULN
Serum glutamic oxaloacetic transaminase (SGOT) < 1.5 x upper limit of normal (ULN)
Serum glutamic oxaloacetic transaminase (SGOT) less than 4.0 times below or above the upper or lower limit range
Serum glutamic-oxaloacetic transaminase (SGOT) < 2 times upper limit of normal (ULN), performed within 28 days prior to registration
Serum glutamic oxaloacetic transaminase (SGOT) > 150 IU or > 3 x upper limit of normal